SCHEMBL9972170

SCHEMBL9972170

C=CCn1c(SC)nc2[nH]c3c(c2c1=O)CCCC3

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.49
▸ LMNA P02545 6/20 0.49
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ MAPT P10636 4/20 0.49
▸ HTT P42858 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ HIF1A Q16665 2/20 0.49
▸ POLB P06746 1/20 0.49
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.41
▸ NPSR1 Q6W5P4 4/20 0.40
▸ GAA P10253 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1101912 0.74 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL1102247 0.72 POLB (0.66) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL14123302 0.66 RXFP1 (0.59) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL1101900 0.64 LMNA (0.77) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL19206540 0.60 ALDH1A1 (0.42) ALDH1A1LMNASMN1; SMN2MAPTKDM4E
SCHEMBL5804877 0.60 NPSR1 (0.65) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL9413995 0.59 ALDH1A1 (0.48) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL19079782 0.59 TSHR (0.73) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL3911841 0.59 TP53 (0.68) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL1101914 0.59 POLB (0.76) ALDH1A1LMNASMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8202861-B2 Drugs for various disorders VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-19 — — US disclosed
US-8202861-B2 Drugs for various disorders VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-19 — — US disclosed
Send feedback